Machine learning operations platform Chief.AI, in partnership with the Medicines Discovery Catapult, has launched the first no-code, pay-as-you-go artificial intelligence (AI) platform for drug discovery.
Medicines Discovery Catapult and the Medical Research Council (MRC) Centre for Drug Safety Science (CDSS) at the University of Liverpool have announced plans...
Medicines Discovery Catapult and AstraZeneca have announced they will team up to advance the adoption of Acoustic Mist Ionisation Mass Spectrometry (AMI-MS) within drug discovery.